Next Article in Journal
Advances in Bract Coloration: Diversity, Pigment Synthesis, and Regulatory Mechanisms in Ornamental Plants
Previous Article in Journal
Effects of Simulated Nitrogen Deposition on the Physiological and Growth Characteristics of Seedlings of Two Typical Subtropical Tree Species
Previous Article in Special Issue
Analytical Characterization and Pharmacokinetic Insight of Bioactive Compounds from Champia parvula and Moringa oleifera for Biocontrol of Blue Mold in Apple Fruits
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Bioassay-Guided Isolation of cis-Clerodane Diterpenoids and Monoglycerides from the Leaves of Solidago gigantea and Their Antimicrobial Activities

1
Plant Protection Institute, HUN-REN Centre for Agricultural Research, Fehérvári út 132-144, 1116 Budapest, Hungary
2
Doctoral School, Semmelweis University, Üllői út 26, 1085 Budapest, Hungary
3
National Collection of Agricultural and Industrial Microorganisms, Institute of Food Science and Technology, Hungarian University of Agriculture and Life Sciences, Somlói út 14-16, 1118 Budapest, Hungary
4
Pharmaceutical Chemistry and Technology Department, National Center for Public Health and Pharmacy, Szabolcs utca 33, 1135 Budapest, Hungary
5
Organocatalysis Research Group, Institute of Organic Chemistry, HUN-REN Research Centre for Natural Sciences, Magyar Tudósok krt. 2, 1117 Budapest, Hungary
*
Author to whom correspondence should be addressed.
Plants 2025, 14(14), 2152; https://doi.org/10.3390/plants14142152
Submission received: 15 June 2025 / Revised: 5 July 2025 / Accepted: 9 July 2025 / Published: 11 July 2025
(This article belongs to the Special Issue Advanced Research in Plant Analytical Chemistry)

Abstract

A previously undescribed cis-clerodane diterpenoid, diangelate solidagoic acid J (1), along with two known cis-clerodane diterpenoids, solidagoic acid C (2) and solidagoic acid D (3), as well as two known unsaturated monoacylglycerols, 1-linoleoyl glycerol (4) and 1-α-linolenoyl glycerol (5), were isolated and characterized from the n-hexane leaf extract of Solidago gigantea (giant goldenrod). Compounds 25 were identified first in this species, and compounds 4 and 5 are reported here for the first time in the Solidago genus. The bioassay-guided isolation procedure included thin-layer chromatography (TLC) coupled with a Bacillus subtilis antibacterial assay, preparative flash column chromatography, and TLC–mass spectrometry (MS). Their structures were elucidated via extensive spectroscopic and spectrometric techniques such as one- and two-dimensional nuclear magnetic resonance (NMR) spectroscopy and high-resolution tandem mass spectrometry (HRMS/MS). The antimicrobial activities of the isolated compounds were evaluated by a microdilution assay. All compounds exhibited weak to moderate antibacterial activity against the Gram-positive plant pathogen Clavibacter michiganensis, with MIC values ranging from 17 to 133 µg/mL, with compound 5 being the most potent. Only compound 1 was active against Curtobacterium flaccumfaciens pv. flaccumfaciens, while compound 3 demonstrated a weak antibacterial effect against B. subtilis and Rhodococcus fascians. Additionally, the growth of B. subtilis and R. fascians was moderately inhibited by compounds 1 and 5, respectively. None of the tested compounds showed antibacterial activity against Gram-negative Pseudomonas syringae pv. tomato and Xanthomonas arboricola pv. pruni. No bactericidal activity was observed against the tested microorganisms. Compounds 2 and 3 displayed weak antifungal activity against the crop pathogens Bipolaris sorokiniana and Fusarium graminearum. Our results demonstrate the efficacy of bioassay-guided strategies in facilitating the discovery of novel bioactive compounds.

1. Introduction

Solidago, commonly referred to as goldenrod, is a large genus within the Asteraceae family, comprising approximately 139 species [1]. S. virgaurea L. is native to Europe. The other goldenrods originate primarily from North America, although four of their representatives have naturalized in Europe: S. gigantea Ait., S. canadensis L., S. altissima L., and Euthamia graminifolia (L.) Nutt. (previously known as S. graminifolia (L.) Salisb.) [2].
S. gigantea Ait. (giant goldenrod) (Figure 1a–c) is a rhizomatous perennial plant that has become a well-known, notorious, and highly invasive species throughout Europe, where its aggressive spread presents a major challenge for biodiversity conservation [3,4]. Among the factors contributing to its successful invasion is its allelopathic potential that enables the plant to suppress the growth of native species by releasing allelochemicals [5]. It is also recognized as a medicinal plant; its aerial, flowering parts (combined with S. canadensis and S. virgaurea) are officially listed as Solidaginis herba in the European Pharmacopoeia [6] and are traditionally used in phytotherapy for their anti-inflammatory, diuretic, and spasmolytic properties [7]. Invasive Solidago weeds, such as S. gigantea, have attracted considerable scientific attention not only due to their ecological impact but also as potential sources of novel bioactive specialized metabolites. The extracts or essential oils obtained from S. gigantea aerial parts exhibit various biological activities, including antibacterial [8], antifungal [9], antimutagenic [6,8], antiproliferative [10], antioxidant [6], and insecticidal [11] effects. These pharmacological activities have been attributed to flavonoids [12,13,14], phenolic acids [12,13,14], monoterpenoids [15,16], sesquiterpenoids [15,16], diterpenoids [17,18,19], and triterpenoids [20,21,22,23].
In our previous work, four antibacterial cis-clerodane diterpenoids, solidagoic acids E, F, H, and I, were isolated from an n-hexane leaf extract of S. gigantea [19]. Encouraged by these findings, our ongoing search for bioactive compounds derived from the invasive goldenrod species was continued [24,25,26,27].
Thus, this work presents non-targeted, effect-directed screening and subsequent highly targeted bioassay-guided fractionation and isolation, followed by the structure elucidation, comprehensive spectroscopic and spectrometric characterization, and microbiological evaluation of compounds contributing to the antibacterial effect of the n-hexane leaf extract of S. gigantea. The methodologies employed included TLC, TLC–direct bioautography (using a Bacillus subtilis antibacterial assay), TLC–MS, preparative flash column chromatography, flow injection analysis (FIA)–heated electrospray ionization (HESI)-tandem high-resolution MS (HRMS/MS), polarimetry, and nuclear magnetic resonance (NMR), UV, and attenuated total reflectance Fourier-transform infrared (ATR–FTIR) spectroscopy. The antibacterial and antifungal activities of the isolated compounds were assessed by in vitro microplate assays against the non-pathogenic soil bacterium B. subtilis and the phytopathogenic bacteria Curtobacterium flaccumfaciens pv. flaccumfaciens, Clavibacter michiganensis, Pseudomonas syringae pv. tomato, Rhodococcus fascians, and Xanthomonas arboricola pv. pruni, as well as the plant pathogenic fungal strains Bipolaris sorokiniana and Fusarium graminearum.

2. Results and Discussion

2.1. Bioassay-Guided Isolation

In our preliminary experiments, the n-hexane leaf extract of S. gigantea displayed antibacterial activity against B. subtilis, observed by an in vitro microdilution assay. To detect potential antibacterial compounds, the n-hexane leaf extract was subjected to a non-targeted, effect-directed screening using TLC–direct bioautography with a B. subtilis antibacterial assay [19]. Four cis-clerodane diterpenoids responsible for the antibacterial effect were identified but the investigation was not exhaustive and focused on flash fractions B43–45 and B46–48, containing slightly more polar compounds compared to this work [19]. Therefore, to identify further bioactive components, the n-hexane leaf extract was subjected to repeated fractionation by preparative flash chromatography (Figure 2a) using normal- (silica gel) and reversed-phase (C18) columns, ultimately returning to silica gel column chromatography, to exploit the orthogonal selectivity of these stationary phases. The purification procedure was continuously monitored by TLC with p-anisaldehyde derivatization (Figure 2b), TLC–B. subtilis direct bioautography (Figure 2c), TLC–MS (Figure 2d,e), and RP-HPLC–ESI-MS. Fractions with similar TLC fingerprints were pooled. The isolation process resulted in five antibacterial compounds obtained from flash fractions B38–39 and B40 (15): 0.8 mg of compound 1 (white amorphous solid), 10.7 mg of compound 2 (white amorphous solid), 9.3 mg of compound 3 (white amorphous solid), 2.4 mg of compound 4 (yellow oil), and 2.1 mg of compound 5 (yellow oil).
With the TLC mobile phase chloroform–ethyl acetate–methanol 15:3:2 (V/V), compound 1 exhibited an RF value of 0.81, compounds 2 and 3 migrated with an RF value of 0.73 and 0.71, respectively, and compounds 4 and 5 migrated with an RF value of 0.59 and 0.58, respectively. After derivatization with p-anisaldehyde, compounds 2 and 3 appeared as pink spots, while compounds 1, 4, and 5 were visualized as dark purple zones on the TLC plates (Figure 2b). All isolated compounds demonstrated strong inhibition zones in the TLC–B. subtilis antibacterial assay (Figure 2c). Note that compounds responsible for the inhibition zone detected in the subfraction B38-39/24-26, marked with an asterisk sign (*) (Figure 2b,c), have not been isolated.

2.2. Structure Elucidation

In this study, one previously undescribed cis-clerodane diterpenoid (1) along with two known cis-clerodane diterpenoids (23) and two known, unsaturated monoglycerides (45) (Figure 3) were isolated. Their structures were elucidated by extensive spectroscopic and spectrometric techniques and comparison with previously reported data. The novelty of the structure of 1 was verified by searching in CAS SciFinder® and Reaxys databases. The recorded one- and two-dimensional NMR (Figures S1–S12 for 1, Figures S19–S25 for 2, Figures S30–S36 for 3, Figures S41–S46 for 4, and Figures S49–S54 for 5), HR-ESI-MS(/MS) (Figures S13–S16 for 1, Figures S26–S29 for 2, Figures S37–S40 for 3, Figures S47 and S48 for 4, and Figures S55 and S56 for 5), UV (Figure S17 for 1), and ATR-FTIR spectra (Figure S18 for 1) of compounds 15 can be found in the Supporting Information.
Solidagoic acid J (1) was obtained as a white amorphous solid. Its molecular formula was established as C30H44O7 deduced from the 13C DEPTQ NMR spectrum and based on the positive- and negative-ion mode HR-ESI-MS signals at m/z 539.2980 [M+Na]+ (calculated for C30H44O7Na+, m/z 539.2979 [M+Na]+; error: 0.1 ppm) and at m/z 515.3013 [M−H] (calculated for C30H43O7, m/z 515.3014 [M−H]; error: −0.3 ppm), indicating nine double bond equivalents (DBEs). Its 1H NMR spectrum (Table 1) revealed proton resonances corresponding to six methyl groups at δH 1.97 (ov., 6H, H3-4′, H3-4″), 1.88 (ov., 3H, H3-5′), 1.86 (ov., 3H, H3-5″), and 0.92 (s, 3H, H3-20), 0.79 (d, J = 6.4 Hz, H3-17), four vinylic hydrogens at δH 6.10 (qq, J = 7.2, 1.3 Hz, 1H, H-3″), 6.04 (qq, J = 7.2, 1.3 Hz, 1H, H-3′), 5.91 (t, J = 4.0 Hz, 1H, H-3), and 5.72 (t, J = 7.1 Hz, 1H, H-14), and three oxymethylene groups at δH 4.80 (d, J = 12.3 Hz, 1H, H2-16a), 4.66 (d, J = 12.3 Hz, 1H, H2-16b), 4.51 (m, 2H, H2-18), and 4.26 (d, J = 7.1 Hz, 2H, H2-15). Based on 13C (Table 1), 1H–13C multiplicity-edited HSQC (edHSQC), and 1H–13C HMBC spectroscopic data, the thirty 13C resonances were assigned to six methyl groups (δC 27.0, 20.8, 20.7, 16.0, 15.9, 15.8), six aliphatic methylene (δC 30.1, 30.0, 29.4, 28.0, 26.5, 19.6) and three oxygenated (δC 64.5, 61.7, 58.7) methylene groups, two aliphatic methine (δC 42.6, 37.0) and four olefinic (δC 139.3, 138.3, 128.7, 128.1) methine groups, and nine non-hydrogenated carbons, including one carboxylic (δC 178.8), two aliphatic (δC 50.0, 38.7), two ester (δC 168.7, 167.7), and four olefinic (δC 139.1, 136.2, 128.0, 127.7) carbons. Thus, the structure of compound 1 exhibited one carboxylic, two ester moieties, and four trisubstituted carbon–carbon double bonds, implying a bicyclic molecule to satisfy the required number of DBEs. In addition, 42 hydrogen atoms could be accounted for, and the remaining two exchangeable hydrogens were assigned to one carboxylic and one hydroxylic group. The ATR-FTIR spectrum featured characteristic, intense bands at 1715 cm−1 (overlapping C=O stretches) and 1648 cm−1 (C=C stretch). These NMR spectroscopic data suggested that compound 1 possessed a clerodane-type diterpene skeleton featuring two methyl groups and two angeloyloxy moieties.
The 1H–1H COSY and 1H–1H TOCSY spectra revealed six distinct spin systems: H-10/H2-1/H2-2/H-3, H2-6/H2-7/H-8/H3-17, H2-11/H2-12, H-14/H2-15, H-3′/H3-4′, and H-3″/H3-4″ (Figure 4). The 6/6 fused A/B ring system (C-1–C-10) bearing two methyl groups (C-17, C-20) and two modified methyl groups (C-18, C-19) was constructed from the spin systems H-10/H2-1/H2-2/H-3 and H2-6/H2-7/H-8/H3-17, and 1H–13C HMBC correlations from H-3 to C-5, from H-10 to C-5, C-6, C-8, and C-9, from H3-17 to C-7, C-8, and C-9, from H2-18 to C-3, C-4, and C-5, and from H3-20 to C-8, C-9, and C-10 (Figure 4). The carboxylic group was assigned to C-5, supported by the HMBC correlations from H2-6a, H2-6b, and H-10 to C-19. The structure of the side chain composed of C-11–C-16 was established by the spin systems H2-11/H2-12 and H-14/H2-15, as well as the HMBC correlations from H2-11 to C-13, from H2-12 to C-13, C-14, and C-16, from H-14 to C-13, C-12, and C-16, and from H2-16 to C-12, C-13, and C-14. The hydroxy group was attached to C-15 as indicated by the downfield 1H and 13C NMR chemical shift of H2-15 (δH 4.26) and C-15 (δC 58.7). The side chain unit was connected to C-9 as inferred from the HMBC correlations from H2-11 to C-9, C-10, and C-20 and from H-8, H-10, and H3-20 to C-11. The presence of two angeloyloxy (Ang) groups was confirmed by the spin systems H-3′/H3-4′ and H-3″/H3-4″ along with HMBC correlations from H-3′ to C-1′, from H3-4′ to C-2′, from H3-5′ to C-1′, C-2′, and C-3′, from H-3″ to C-1″, from H3-4″ to C-2″, and from H3-5″ to C-1″, C-2″, and C-3″. This was further verified by the MS fragmentation of the precursor ion at m/z 539.2979 [M+Na]+, which resulted in the formation of fragment ions at m/z 439.2454 [M+Na–C5H8O2]+ and at m/z 339.1930 [M+Na–C10H16O4]+, indicating the successive losses of two Ang groups (C5H8O2). Additionally, the MS fragmentation of the parent ion at m/z 515.3014 [M−H] yielded a product ion at m/z 99.0452, corresponding to an angelate ion (C5H7O2). The two angeloyloxy groups were linked to C-16 and C-18 based on the HMBC correlations from H2-16 to C-1″ and H2-18 to C-1′, respectively. This assignment was corroborated by the downfield 1H and 13C NMR chemical shifts of H2-16a (δH 4.80), H2-16b (δH 4.66), and C-16 (δC 61.7) as well as H2-18 (δH 4.51) and C-18 (δC 64.5), respectively.
After determining the planar structure, the relative configuration of compound 1 was elucidated using a combination of 1H–1H ROESY correlations, diagnostic 1H–1H spin–spin coupling constants, 1H and 13C NMR chemical shift analysis, 13C NMR-based empirical rules, and comparison with data from the literature. The 13C NMR chemical shift difference in the resonance between C-17 and C-20 exceeding 10 ppm (∆δC-20–C-17 = 11.2 ppm) suggested the cis relative configuration of the A/B ring junction and the trans relationship between the C-17 and C-20 methyl groups (characteristic of a cistrans (CT)-type clerodane diterpene skeleton) [28,29]. The cis-A/B ring fusion was further proved by the downfield 13C NMR chemical shift of C-20 (δC 27.0); in trans-clerodanes, C-20 typically resonates between δC 17–19, whereas in cis-clerodanes, this resonance appears between δC 21–29 [30]. Furthermore, a downfield 1H NMR chemical shift of H3-20 (δH 0.92) relative to H3-17 (δH 0.79) also supports the presence of a cis-A/B ring junction [29]. The CT-type clerodane diterpene skeleton with a nonsteroidal conformation was confirmed by NOE enhancements between H3-17/H3-20, H3-17/H2-11b, H3-20/H2-1a, H3-20/H-8, and H3-20/H-10 and by the axial orientation of H-10 [28], which was revealed by its coupling constants of 12.9 Hz (axial–axial coupling with H2-1b) and 1.5 Hz (axial–equatorial coupling with H2-1a). The NOE interactions between H-3′/H3-5′ and H-3″/H3-5″ along with the absence of NOE correlations between H3-4′/H3-5′ and H3-4″/H3-5″ implied that the esterified group was an angelate ((2Z)-2-methylbut-2-enoate) with a Z double bond geometry. The presence of the angeloyloxy rather than the isomeric tigloyloxy moieties was confirmed by comparing the 1H NMR chemical shift of H-3′ (δH 6.04) and H-3″ (δH 6.10) with reference values from the literature: δH 6.06 for methyl angelate and δH 6.90 for methyl tiglate [31]. Finally, the ROESY spectrum featured cross-peaks between H2-12a/H-14, H2-12b/H-14, H2-11a/H-14, H2-11b/H-14, H2-15/H2-16a, and H2-15/H2-16b, although no correlation was observed between H-14/H2-16 and H2-12/H2-15, which is consistent with the Z configuration of the double bond C-13–C-14.
Solidagoic acids A and B were first isolated from the roots of S. gigantea [32], while solidagoic acids C–I were first reported from natural sources from the aerial parts of S. virgaurea [33]. Based on the structural similarity of compound 1 to solidagoic acids A–I, this previously undescribed cis-clerodane diterpenoid is herein assigned the trivial name solidagoic acid J, and its absolute configuration was given by analogy with solidagoic acids A–I. It should be noted that the specific rotation of compound 1 could not be reliably determined, owing to the limited sample quantity.
In addition, four known compounds, 25 (Figure 3), were identified based on their NMR and HRMS(/MS) data. Comparison of their spectroscopic and spectrometric data with values from the literature confirmed them as two cis-clerodane diterpenoids, solidagoic acid C (2) [33] and solidagoic acid D (3) [33], as well as two unsaturated monoacylglycerols, 1-linoleoyl glycerol (2,3-dihydroxypropyl (9Z,12Z)-9,12-octadecadienoate, 1-monolinolein) (4) [34,35] and 1-α-linolenoyl glycerol (2,3-dihydroxypropyl (9Z,12Z,15Z)-9,12,15-octadecatrienoate, 1-monolinolenin) (5) [34]. Due to the insufficient sample quantities and the low specific rotations [34,36,37], the enantiopurity and the absolute configuration of the C-2 chirality centre in compounds 4 and 5 could not be reliably determined.
Clerodane diterpenoids are a class of naturally occurring specialized metabolites known for their diverse biological and pharmacological activities, including antibacterial, antifungal, antitumor, insect antifeedant, anti-inflammatory, antiplasmodial, antiulcer, and cytotoxic effects [38]. Solidagoic acid J (1) is an undescribed cis-clerodane diterpenoid that has not yet been synthesized. Solidagoic acid C (2) was first prepared by Anthonsen et al. [32] and later isolated from the aerial parts of S. virgaurea [33]. It was also detected in the ethanolic leaf extract of E. graminifolia [39]. Solidagoic acid D (3) was similarly isolated from the aerial parts of S. virgaurea [33]. Solidagoic acids E and F, previously isolated by us from the leaves of S. gigantea [19], are the 15-hydroxy derivatives of solidagoic acids C (2) and D (3), respectively, indicating that the present study focused on slightly less polar compounds.
Monoacylglycerols, also known as monoglycerides, are low-abundance, transient glycerolipids that play a crucial role as intermediates in the lipid metabolism with antibacterial [40], antifungal [40], antiprotozoal [41], and antiviral [42] activities. The monoacylglycerols 1-linoleoyl glycerol (4) and 1-α-linolenoyl glycerol (5) were detected, identified, and isolated from various plant species [34,43,44,45,46] though not from the Solidago genus. Thus, compounds 25 were identified and isolated for the first time from S. gigantea, with compounds 4 and 5 also being first reported here from the Solidago genus.

2.3. Antimicrobial Assays

The antimicrobial potential of the isolated compounds (15) was evaluated against Gram-positive, non-pathogenic B. subtilis and a series of bacterial and fungal phytopathogens that were selected based on their relevance as common strains frequently associated with various plant diseases. Namely, the following pathogens were involved in this study: the Gram-positive pathogens C. flaccumfaciens pv. flaccumfaciens, isolated from bean; C. michiganensis (formerly C. michiganensis subsp. michiganensis), the causal agent of bacterial canker on tomato and R. fascians, isolated from chrysanthemum; the Gram-negative pathogens P. syringae pv. tomato, which infects tomato, and Arabidopsis thaliana; X. arboricola pv. pruni, which causes bacterial leaf and fruit spot on stone fruits; and the crop-pathogenic fungal strains B. sorokiniana and F. graminearum. The antibacterial, bactericidal, and antifungal activities of the isolates were compared to those of the respective positive controls, gentamicin (for bacteria) and benomyl (for fungi). The minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values are depicted in Table 2.
As described in Table 2, compound 1 exhibited weak to moderate antibacterial activity against B. subtilis, C. flaccumfaciens pv. flaccumfaciens, and C. michiganensis with MIC values ranging from 67 to 133 μg/mL. For compound 1, MIC and MBC values against certain bacterial strains could not be determined due to insufficient sample quantity. Compounds 2 and 4 showed a weak to moderate antibacterial effect only against C. michiganensis with MIC values of 133 and 33 μg/mL, respectively. Compounds 3 and 5 demonstrated weak to moderate antibacterial activity against C. michiganensis (MIC 33 and 17 μg/mL, respectively) and R. fascians (MIC 133 and 33 μg/mL, respectively). A weak antibacterial effect was also observed against B. subtilis for compound 3 with a MIC value of 133 μg/mL. Notably, only compound 1 was active against C. flaccumfaciens pv. flaccumfaciens, also inhibiting C. michiganensis with MIC values of 67 μg/mL However, the antibacterial activity of the positive control (antibiotic gentamicin) surpassed that of the tested compounds by 1–2 orders of magnitude. None of the isolates inhibited the bacterial growth of the Gram-negative P. syringae pv. tomato and X. arboricola pv. pruni. This fact may be attributed to the differences in the structural and functional properties of Gram-negative bacterial cell walls compared to those of Gram-positive bacteria, which often act as a barrier to many antibacterial agents [47]. Compounds 2 and 3 displayed a moderate antifungal effect against B. sorokiniana with 45% and 56% and against F. graminearum with 56% and 51% mycelium growth inhibition at the highest concentration (333 μg/mL), respectively. None of the isolated compounds demonstrated bactericidal activity at the tested concentrations, suggesting a bacteriostatic mode of action. Regarding structure–activity relationships, an angelate group in clerodane diterpenoids (compound 3 compared to 2) was shown to enhance the antibacterial activity. Similarly, the presence of an additional double bond improved the antibacterial effect of monoglycerides (compound 5 compared to compound 4).
Compounds 2 and 3 demonstrated moderate antibacterial activity against Staphylococcus aureus with MIC values of 60 and 30 µg/mL, respectively [33]. Compound 4 displayed antifungal inhibitory rates exceeding 50% against Trichophyton mentagrophytes [48]. Additionally, its antimicrobial effect was reported in an agar diffusion assay against a range of fungi, Emericellopsis minima, Microascus sp., Monochaetia sp., Phoma sp., and Scopulariopsis candida, all of them isolated from marine sponges [49]. Notably, 1-linoleoyl-(2R) glycerol was found to be more potent than its (S) enantiomer against B. subtilis (MIC 200 µg/mL vs. >200 µg/mL) and S. aureus (MIC 100 µg/mL vs. 200 µg/mL) [36]. However, it exhibited no antibacterial activity against Erysipelothrix rhusiopathiae (MIC > 100 µg/mL), Escherichia coli (MIC > 100 µg/mL), Streptococcus suis (MIC > 100 µg/mL), and Pseudomonas aeruginosa [50] and no antifungal effect (MIC > 100 µg/mL) was observed against the fungi Botrytis cinerea, Verticillium dahliae, F. graminearum, Fusarium oxysporum, and Rhizoctonia solani [50]. Our results are in agreement with data from the literature (MIC > 133 µg/mL against both B. subtilis and F. graminearum). The MIC value of compound 5 against B. subtilis was reported to be 400 µg/mL [51], which is consistent with the lack of inhibition at 133 µg/mL in the present study.

3. Materials and Methods

3.1. Materials

Glass- and aluminum-backed HPTLC and TLC silica gel 60 F254 plates (all 20 × 10 cm) were purchased from Merck (Darmstadt, Germany). Xprep preparative silica gel (pore size: 6.65 nm, particle size: 230–400 mesh) was supplied by LAB-EX (Budapest, Hungary). All chemicals were used as received from commercial suppliers without further purification. Solvents of analytical grade (acetone, tert-butyl alcohol, chloroform (stabilized with 5–50 ppm amylene), ethyl acetate, n-hexane, isopropyl alcohol, methanol) and gradient-grade methanol were obtained from Molar Chemicals (Halásztelek, Hungary). LC-MS-grade methanol was purchased from VWR (Radnor, PE, USA), while LC-MS-grade water was from Reanal (Budapest, Hungary). Bidistilled water was prepared by a Vitrotech VDB-3A apparatus (Vitro-Tech-Lab Ltd., Gyál, Hungary). Ultrapure water was generated by a Millipore Direct-Q 3 UV Water Purification System (Merck). Benomyl, formic acid (LC-MS grade), gentamicin, and p-anisaldehyde were from Sigma-Aldrich (Burlington, MA, USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was acquired from Carl Roth (Karlsruhe, Germany), concentrated sulfuric acid (96%) from Carlo Erba (Milan, Italy), and acetic acid from Lach-Ner (Neratovice, Czech Republic). For NMR spectroscopy, chloroform-d (99.8 atom% D) was purchased from Eurisotop (Saint-Aubin, France) or Merck. Tryptone (from casein, pancreatic digest) and sodium chloride were obtained from Reanal, agar from Merck, and yeast extract from Scharlab (Barcelona, Spain). Nutrient Broth (NB) was from Biolab (Budapest, Hungary). The Gram-positive soil bacterium Bacillus subtilis (F1276) was a gift from József Farkas (Central Food Research Institute, Budapest, Hungary). Curtobacterium flaccumfaciens pv. flaccumfaciens (NCAIM B.01609) and Clavibacter michiganensis (NCAIM B.01813) were received from Dénes Dlauchy (National Collection of Agricultural and Industrial Microorganisms, Budapest, Hungary). Fusarium graminearum Schwabe (NCAIM F.00730) and Rhodococcus fascians (NCAIM B.01608) were purchased from the National Collection of Agricultural and Industrial Microorganisms (NCAIM, Budapest, Hungary). The Xanthomonas arboricola pv. pruni strain was isolated from Prunus armeniaca L. cv. Bergecot in 2016 (No. XapHU1, I. Schwarczinger, Plant Protection Institute, HUN-REN Centre for Agricultural Research, Budapest, Hungary). Bipolaris sorokiniana (Sacc.) Shoemaker H-299 (NCBI GenBank accession No. MH697869) was collected from barley in Hungary. Pseudomonas syringae pv. tomato DC3000 Lux was donated by Julia Vorholt (ETH Zurich, Zurich, Switzerland).

3.2. Plant Material

The leaves of S. gigantea were collected in July 2020 near Harta, Hungary (46° 41′ 51.5″ N 19° 02′ 52.4″ E, altitude: 90 m a. s. l.). A voucher specimen (Figure 1c) has been deposited at the Hungarian Natural History Museum, Budapest, Hungary, under the accession number HNHM-TRA 00027284. The fresh plant material was dried at room temperature and powdered with a coffee grinder (Sencor SCG 2050, Říčany, Czech Republic).

3.3. (High-Performance) TLC–UV/FLD Method

Samples were applied manually by a 10 µL microsyringe (Hamilton, Bonaduz, Switzerland) as 5 mm bands with 6–10 mm track distance and 8 mm distance from the lower edge on high-performance (HP)TLC silica gel 60 F254 plates (Merck). (HP)TLC separation was carried out in a pre-saturated (for 10 min) twin-trough chamber (CAMAG, Muttenz, Switzerland) with the mobile phase chloroform–ethyl acetate–methanol, 15:3:2 (V/V) up to 70 mm from the lower plate edge. After development, the plates were dried in a cold air stream of a hair dryer and documented with a digital camera (Cybershot DSC-HX60, Sony, Neu-Isenberg, Germany) under a UV lamp (CAMAG) at 254 nm and 366 nm.

3.3.1. Detection via p-Anisaldehyde Sulfuric Acid Reagent

For the derivatization, the developed (HP)TLC chromatoplates were dipped into the p-anisaldehyde sulfuric acid reagent (500 μL of p-anisaldehyde, 10 mL of acetic acid, 100 mL of methanol, and 5 mL of concentrated sulfuric acid (96%)), followed by heating at 110 °C for 5 min (Advanced Hot Plate, VWR) and detecting at Vis under white light illumination in the transmittance mode (96891 Salobrena 2 LED lamp, EGLO Lux, Dunakeszi, Hungary).

3.3.2. Detection via Planar B. subtilis Antibacterial Assay

The TLC–B. subtilis bioassay was performed according to the protocol previously described [52]. Briefly, the developed and dried TLC plates were immersed in the bacterial cell suspension (OD600 = 1.2) and then incubated for 2 h in a vapor chamber (at 37 °C and 100% relative humidity). Subsequently, the plates were immersed in an aqueous MTT solution (1 mg/mL) and incubated for an additional 15 min. The bioautograms were documented under visible light, where antibacterial compounds appeared as bright inhibition zones against a purplish background.

3.4. Extraction and Isolation

The air-dried, powdered leaves (100 g) of S. gigantea were extracted by maceration with n-hexane (3 × 700 mL, each for 72 h) at room temperature. The filtered (Reanal filter paper; pore size: 7–10 μm) and combined n-hexane crude extract was concentrated at 40 °C under reduced pressure with a rotary evaporator (Rotavapor R-134, Büchi, Flawil, Switzerland) to afford a dry residue (9.8 g). It was subjected to manual normal-phase column chromatography using a silica gel column (30 g) with stepwise gradient elution (chloroform–acetone 19:1, V/V; n-hexane–acetone 1:1, V/V; acetone) to obtain fractions A-C. The solvent flow was accelerated by applying external pressure with an air compressor (HYD-24F, Hyundai, Seoul, Republic of Korea). Fraction B (3.65 g) was dried with a rotary evaporator, re-suspended in n-hexane, and subjected to normal-phase flash column chromatography (CombiFlash NextGen 300, Teledyne Isco, Lincoln, NE, USA) using a silica gel column (RediSep Rf Gold, 20–40 μm, 40 g) with a gradient solvent system of n-hexane and acetone (0–0.5 min, 0%; 0.5–20.5 min, 0–30%; 20.5–25.5 min, 30–50%; 25.5–27.5 min, 50–100% acetone; flow rate: 30 mL/min), yielding 67 fractions. Fractions B38-39 (354 mg) and B40 (256 mg) were separately purified by reversed-phase flash column chromatography on a C18 column (RediSep Rf Gold C18, 20–40 μm, 30 g) using a gradient solvent system of water with 0.1% formic acid and methanol (0.0–0.6 min, 0%; 0.6–1.2 min, 0–65%; 1.2–34.4 min, 65–100% methanol; flow rate: 20 mL/min) to furnish 53-53 subfractions, respectively. Subfraction B38-39/24-26 (20.5 mg) was further separated by normal-phase flash column chromatography using a silica gel column (RediSep Rf Gold, 20–40 μm, 24 g) with an isocratic elution of n-hexane–tert-butyl alcohol 23:2, V/V (flow rate: 20 mL/min) to obtain compound 2 (subfraction B38-39/24-26/18-24, tR = 11.7–16.5 min, 10.7 mg). Subfraction B38-39/38-40 (4.9 mg) was purified by normal-phase flash column chromatography using a silica gel column (RediSep Rf Gold, 20–40 μm, 12 g) with a gradient solvent system of n-hexane and isopropyl alcohol (0.0–0.5 min, 0%; 0.5–20.5 min, 0–10%; 20.5–22.5 min, 10–100% isopropyl alcohol; flow rate: 20 mL/min) to give compound 1 (subfraction B38-39/38-40/17, tR = 9.5–10.5 min, 0.8 mg) and compound 4 (subfraction B38-39/38-40/22-23, tR = 14.3–16.2 min, 2.4 mg). Subfractions B40/30-32 (10.5 mg) and B40/36-38 (2.3 mg) were separately subjected to normal-phase flash column chromatography using a silica gel column (RediSep Rf Gold, 20–40 μm, 12 g) with an isocratic elution of n-hexane–acetone 4:1, V/V (flow rate: 10 mL/min) to obtain compound 3 (subfraction B40/30-32/15-30; tR = 18.5–27.8 min; 9.3 mg) and compound 5 (subfraction B40/36-38/11-12, tR = 14.9–18.7 min, 2.1 mg), respectively.

3.5. Compound Characterization

Solidagoic acid J (1): White amorphous solid; UV (EtOH) λmax (log ε) 205 nm (3.81), 209 nm (3.80); IR (ATR) νmax 3429, 2958, 2926, 2856, 1715, 1648, 1546, 1457, 1439, 1381, 1354, 1260, 1231, 1190, 1155, 1085, 1043, 1027, 971, 911 cm−1; 1H (500 MHz, CDCl3) and 13C (126 MHz, CDCl3) NMR spectroscopic data, see Table 1; HR-ESI-MS m/z 539.2980 [M+Na]+ (calculated for C30H44O7Na+, m/z 539.2979 [M+Na]+, error: 0.1 ppm), m/z 515.3013 [M−H] (calculated for C30H43O7, m/z 515.3014 [M−H], error: −0.3 ppm); TLC: RF 0.81 (chloroform–ethyl acetate–methanol 15:3:2, V/V).
Solidagoic acid C (2): White amorphous solid; 1H NMR (500 MHz, CDCl3) δ 7.16 (p, J = 1.2 Hz, 1H, H-14), 5.53 (t, J = 4.0 Hz, 1H, H-3), 4.76 (m, 2H, H2-15), 2.53 (td, J = 13.8, 1.7 Hz, 1H, H2-12b), 2.35 (ov., 1H, H-10), 2.32 (ov., 1H, H2-6a), 2.17 (td, J = 13.3, 4.7 Hz, 1H, H2-12a), 2.10 (m, 2H, H2-2), 1.73 (m, 1H, H2-1a), 1.70 (ov., 1H, H2-11a), 1.65 (ov., 1H, H-8), 1.65 (ov., 1H, H2-7a), 1.58 (q, J = 1.8 Hz, 3H, H3-18), 1.53 (m, 1H, H2-1b), 1.42 (m, 1H, H2-6b), 1.34 (m, 1H, H2-7b), 1.20 (td, J = 13.7, 5.0 Hz, 1H, H2-11b), 0.98 (s, 3H, H3-20), 0.80 (d, J = 5.9 Hz, 3H, H3-17); 13C NMR (126 MHz, CDCl3) δ 179.6 (C, C-19), 175.8 (C, C-16), 146.1 (CH, C-14), 136.0 (C, C-4), 135.4 (C, C-13), 123.6 (CH, C-3), 70.5 (CH2, C-15), 51.0 (C, C-5), 42.6 (CH, C-10), 38.9 (C, C-9), 37.1 (CH, C-8), 31.3 (CH2, C-11), 29.3 (CH2, C-6), 28.0 (CH2, C-7), 26.9 (CH3, C-20), 26.6 (CH2, C-2), 20.1 (CH2, C-12), 19.7 (CH2, C-1), 19.1 (CH3, C-18), 15.9 (CH3, C-17); HR-ESI-MS m/z 355.1879 [M+Na]+ (calculated for C20H28O4Na+, m/z 355.1880 [M+Na]+, error: −0.1 ppm), m/z 331.1915 [M−H] (calculated for C20H27O4, m/z 331.1915 [M−H], error: −0.1 ppm); TLC: RF 0.73 (chloroform–ethyl acetate–methanol 15:3:2, V/V).
Solidagoic acid D (3): White amorphous solid; 1H NMR (500 MHz, CDCl3) δ 7.18 (br s, 1H, H-14), 6.04 (qq, J = 7.3, 1.6 Hz, 1H, H-3′), 5.93 (t, J = 4.1 Hz, 1H, H-3), 4.78 (q, J = 1.4 Hz, 2H, H2-15), 4.53 (m, 2H, H2-18), 2.53 (br t, J = 13.3 Hz, 1H, H2-12a), 2.42 (ov., 1H, H2-6a), 2.40 (ov., 1H, H-10), 2.20 (m, 2H, H2-2), 2.17 (ov., 1H, H2-12b), 1.98 (dq, J = 7.3, 1.6 Hz, 3H, H3-4′), 1.89 (p, J = 1.6 Hz, 3H, H3-5′), 1.77 (ov., 1H, H2-1a), 1.76 (ov., 1H, H2-11a), 1.67 (ov., 1H, H2-7a), 1.66 (ov., 1H, H-8), 1.57 (ov., 1H, H2-1b), 1.53 (ov., 1H, H2-6b), 1.33 (ov., 1H, H2-7b), 1.16 (ov., 1H, H2-11b), 0.99 (s, 3H, H3-20), 0.80 (d, J = 6.1 Hz, 3H, H3-17); 13C NMR (126 MHz, CDCl3) δ 178.3* (C, C-19), 175.9 (C, C-16), 167.7 (C, C-1′), 146.4 (CH, C-14), 138.3 (CH, C-3′), 135.8* (C, C-4), 135.5 (C, C-13), 128.2* (C, C-2′), 128.0 (CH, C-3), 70.6 (CH2, C-15), 64.4 (CH2, C-18), 50.0 (C, C-5), 42.7 (CH, C-10), 39.0 (C, C-9), 37.0 (CH, C-8), 31.5 (CH2, C-11), 30.0 (CH2, C-6), 28.0 (CH2, C-7), 27.1 (CH3, C-20), 26.6 (CH2, C-2), 20.7 (CH3, C-5′), 20.1 (CH2, C-12), 19.7 (CH2, C-1), 15.9 (CH3, C-4′), 15.8 (CH3, C-17); HR-ESI-MS m/z 453.2247 [M+Na]+ (calculated for C25H34O6Na+, m/z 453.2248 [M+Na]+, error: 0.1 ppm), m/z 429.2280 [M−H] (calculated for C25H33O6, m/z 429.2283 [M−H], error: −0.5 ppm); TLC: RF 0.71 (chloroform–ethyl acetate–methanol 15:3:2, V/V).
1-Linoleoyl glycerol (4): Yellow oil; 1H NMR (500 MHz, CDCl3) δ 5.34 (m, 4H, H-9, H-10, H-12, H-13), 4.21 (dd, J = 11.4, 4.8 Hz, 1H, H2-1′a), 4.15 (dd, J = 11.4, 6.0 Hz, 1H, H2-1′b), 3.93 (m, 1H, H-2′), 3.70 (dd, J = 11.4, 3.6 Hz, 1H, H2-3′a), 3.60 (dd, J = 11.4, 6.0 Hz, 1H, H2-3′b), 2.77 (t, J = 6.9 Hz, 2H, H2-11), 2.34 (t, J = 7.7 Hz, 2H, H2-2), 2.03 (m, 4H, H2-8, H2-14), 1.63 (m, 2H, H2-3), 1.31 (m, 14H, H2-4, H2-5, H2-6, H2-7, H2-15, H2-16, H2-17), 0.87 (m, 3H, H3-18); 13C NMR (126 MHz, CDCl3) δ 174.4* (C, C-1), 130.4/130.2 (CH, C-9/C-13), 128.3/128.1 (CH, C-10/C-12), 70.5 (CH, C-2′), 65.4 (CH2, C-1′), 63.5 (CH2, C-3′), 34.3 (CH2, C-2), 31.7 (CH2, C-16), 29.8/29.7/29.5/29.3/29.2 (CH2, C-4/C-5/C-6/C-7/C-15), 27.4/27.3 (CH2, C-8/C-14), 25.8 (CH2, C-11), 25.1 (CH2, C-3), 22.7 (CH2, C-17), 14.3 (CH3, C-18); HR-ESI-MS m/z 377.2662 [M+Na]+ (calculated for C21H38O4Na+, m/z 377.2662 [M+Na]+, error: 0.0 ppm); m/z 355.2843 [M+H]+ (calculated for C21H39O4+, m/z 355.2843 [M+H]+, error: 0.0 ppm); TLC: RF 0.59 (chloroform–ethyl acetate–methanol 15:3:2, V/V).
1-α-Linolenoyl glycerol (5): Yellow oil; 1H NMR (500 MHz, CDCl3) δ 5.36 (m, 6H, H-9, H-10, H-12, H-13, H-15, H-16), 4.21 (dd, J = 11.6, 4.3 Hz, 1H, H2-1′a), 4.15 (dd, J = 11.6, 6.0 Hz, 1H, H2-1′b), 3.93 (m, 1H, H-2′), 3.70 (dd, J = 11.5, 3.9 Hz, 1H, H2-3′a), 3.60 (dd, J = 11.5, 5.7 Hz, 1H, H2-3′b), 2.81 (t, J = 6.3 Hz, 4H, H2-11, H2-14), 2.35 (t, J = 7.6 Hz, 2H, H2-2), 2.07 (m, 4H, H2-8, H2-17), 1.63 (m, 2H, H2-3), 1.32 (m, 8H, H2-4–H2-7), 0.98 (t, J = 7.5 Hz, 3H, H3-18); 13C NMR (126 MHz, CDCl3) δ 174.4* (C, C-1), 132.1 (CH, C-16), 130.4 (CH, C-9/C-10), 128.5/128.4 (CH, C-12/C-13), 127.9 (CH, C-9/C-10), 127.3 (CH, C-15), 70.5 (CH, C-2′), 65.4 (CH2, C-1′), 63.5 (CH2, C-3′), 34.3 (CH2, C-2), 29.9/29.7/29.3/29.2 (CH2, C-4/C-5/C-6/C-7), 27.4 (CH2, C-8), 25.8/25.7 (CH2, C-11/C-14), 25.1 (CH2, C-3), 20.7 (CH2, C-17), 14.4 (CH3, C-18).; HR-ESI-MS m/z 375.2506 [M+Na]+ (calculated for C21H36O4Na+, m/z 375.2506 [M+Na]+, error: 0.0 ppm); m/z 353.2686 [M+H]+ (calculated for C21H37O4+, m/z 353.2686 [M+H]+, error: 0.0 ppm); TLC: RF 0.58 (chloroform–ethyl acetate–methanol 15:3:2, V/V).
Chemical shifts marked with an asterisk sign (*) were determined from HMBC spectra. The multiplicity of overlapped (ov.) resonances is not reported.

3.6. TLC–ESI-MS

For TLC–MS, methanol was delivered at a flow rate of 0.2 mL/min by a binary HPLC pump (LC-20AB, Shimadzu, Kyoto, Japan) through the oval elution head (4 mm × 2 mm) of the TLC-MS Interface 2 (CAMAG) into a single quadrupole electrospray ionization mass spectrometer (LCMS-2020, Shimadzu). The mass spectrometric conditions were as follows: the nebulizer gas (N2) flow rate, 1.5 L/min; the drying gas (N2) flow rate, 10 L/min; the interface temperature, 350 °C; the heat block temperature, 400 °C, and the desolvation line temperature, 250 °C. The detector voltage was set to +4.5 kV in positive and −4.5 kV in negative ionization modes. Full scan mass spectra were recorded in positive and negative ionization modes in the m/z range of 200–950, with a scan speed of 790 amu/s. Instrument control, data acquisition, and data analysis were performed using the LabSolutions software version 5.42v (Shimadzu).

3.7. FIA–HR-HESI-MS(/MS)

HR-HESI-MS(/MS) spectra of the isolated compounds were acquired via flow injection analysis (FIA). A UHPLC (Vanquish Flex VF-P10, Dionex Softron, Germering, Germany) instrument was coupled to a hybrid quadrupole-orbitrap mass spectrometer equipped with an HESI-II probe (Orbitrap Exploris 120, Thermo Fisher Scientific, Bremen, Germany). The flow rate of methanol was 0.2 mL/min. Full scan mass spectra were obtained in both positive and negative ionization modes in the range of m/z 100–1000 with a resolution of 120,000. The spray voltage was set to 3.4 kV in positive mode and −2.0 kV in negative mode. The ion transfer tube temperature was maintained at 320 °C and the vaporizer temperature at 250 °C. Nitrogen, produced by a Peak Scientific gas generator (Genius XE 35, Glasgow, UK), was used as both sheath and auxiliary gas at flow rates of 10 and 5 arbitrary units, respectively.
Tandem mass (MS/MS) spectra were recorded in HCD fragmentation mode using normalized collision energies ranging from 20% to 60%. Precursor ions were selected with a quadrupole isolation window of m/z 0.4. MS/MS spectra were acquired with a resolution of 120,000 without lock mass correction. Instrument control and data processing were carried out using Xcalibur software version 4.7.69 (Thermo Fisher Scientific).

3.8. NMR Spectroscopy

Samples were dissolved in chloroform-d (CDCl3) and transferred to standard 5 mm NMR tubes for analysis. All NMR spectra were acquired on either a Varian Unity INOVA 500 (1H: 499.6 MHz, 13C: 125.7 MHz; 11.7 T) spectrometer equipped with an inverse-detection pulsed-field gradient (IDPFG) probe head or a Bruker AVANCE III 500 (1H: 500.1 MHz, 13C: 125.8 MHz; 11.7 T) spectrometer equipped with a 5 mm triple-resonance, z-gradient cryoprobe (CP TCI 500S2 H-C/N-D-05 Z) (Bruker Corporation, Billerica, MA, USA) at 303 or 296 K, respectively. The instruments were operated and controlled by VnmrJ 4.2 or Bruker TopSpin 3.5 software. All standard pulse sequences were taken from the spectrometer software libraries (VnmrJ 4.2 or TopSpin 3.5). 1H and 13C chemical shifts are reported on the delta (δ) scale as parts per million (ppm) referenced to the NMR solvent used (CHCl3 residual peak at δH = 7.26 ppm and CDCl3 at δC = 77.16 ppm). Spin–spin coupling constant (J) values are reported in hertz (Hz). Signal multiplicities are denoted as follows: s—singlet; br s—broad singlet; d—doublet; t—triplet; br t—broad triplet; q—quartet; p—pentet; m—multiplet; dd—doublet of doublets; dt—doublet of triplets; td—triplet of doublets; dq—doublet of quartets; and qq—quartet of quartets. The complete 1H and 13C resonance assignments were carried out using conventional one-dimensional (1D) 1H, 13C, and 13C DEPTQ as well as two-dimensional (2D) homonuclear 1H–1H COSY, 1H–1H double-quantum-filtered (DQF)-COSY, 1H–1H TOCSY, 1H–1H ROESY, and heteronuclear 1H–13C multiplicity-edited HSQC (edHSQC) and 1H–13C HMBC (optimized for nJC–H = 8 Hz) experiments. For compound 1, 2D band-selective 1H–13C HSQC and HMBC spectra were also acquired to enhance the spectral resolution in the F1 dimension.

3.9. Polarimetry, UV, and ATR-FTIR Spectroscopy

3.9.1. Polarimetry

Optical rotations were recorded at 25 °C at the sodium D-line (589.3 nm) using a PerkinElmer 341 LC polarimeter (PerkinElmer, Waltham, MA, USA) with an optical path length of 1 dm. Chloroform was used as a solvent.

3.9.2. UV Spectroscopy

UV spectra were obtained using a PerkinElmer Lambda 35 spectrophotometer at room temperature. The spectra were acquired in the range of 190–400 nm with a scan speed of 60 nm/min and a slit width of 1 nm. Data processing and analysis were performed by the UV WinLab 5.2.0.0646 software.

3.9.3. ATR-FTIR Spectroscopy

ATR-FTIR spectra were recorded using a PerkinElmer Spectrum 400 FT-IR/FT-NIR spectrometer equipped with a diamond/ZnSe ATR crystal and a MIR TGS detector. The spectra were collected in the range of 4000–650 cm−1 with a spectral resolution of 4 cm−1, averaging 32 scans. Data were processed and analyzed by PerkinElmer Spectrum Software version 6.3.1.

3.10. In Vitro Antimicrobial Activity Assays

3.10.1. Determination of Minimal Inhibitory Concentration (MIC) Values

B. subtilis was cultured in Luria–Bertani (LB) broth (10 g/L tryptone, 5 g/L yeast extract, 10 g/L sodium chloride) at 37 °C for 24 h, P. syringae pv. tomato in LB broth at 28 °C for 24 h, C. flaccumfaciens pv. flaccumfaciens, C. michiganensis, and X. arboricola pv. pruni in Nutrient Broth (11 g/L peptones, 5 g/L sodium chloride) at 28 °C for 24 h, and R. fascians in Waksman broth (5 g/L peptone, 5 g/L meat extract, 5 g/L sodium chloride, 10 g/L glucose, pH adjusted to 7.2 with a 40% aqueous sodium hydroxide solution) at 30 °C for 24 h. Prior to the antibacterial assays, each bacterial suspension was diluted with the broth specified above to reach 105 CFU/mL. F. graminearum and B. sorokiniana were grown in LB broth at 21 °C for 72 h by shaking at 120 rpm. Prior to the antifungal assays, mycelia were washed in fresh LB medium and fragmented using a FastPrep®-24 Classic homogenizer (MP Biomedicals, Irvine, CA, USA). The mycelia were suspended in 1 mL of the same medium and transferred into 2 mL Eppendorf tubes containing 7 glass beads (2 mm diameter). Homogenization was performed at an acceleration of 4.5 m/s for 2 × 20 s and finally a mycelium suspension of OD600 = 0.2 was prepared in LB broth.
The in vitro antimicrobial activities of the isolated compounds were evaluated based on their minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values against the Gram-positive B. subtilis, C. flaccumfaciens pv. flaccumfaciens, C. michiganensis, and R. fascians and the Gram-negative P. syringae pv. tomato, and X. arboricola pv. pruni bacterial strains as well as against the F. graminearum and B. sorokiniana fungal strains using a microplate assay as previously described [24] with minor modifications. For the antibacterial assays, non-treated, flat-bottom 96-well microplates (VWR, cat #734-2781) were used, whereas for the antifungal assays, non-treated, U-bottom, 96-well microtiter plates (Nest Scientific, Woodbridge, NJ, USA, cat #701111) were utilized. A two-fold ethanolic dilution series of 10 µL of the isolates (for antibacterial assays, 2 mg/mL in ethanol for each compound, whereas for antifungal assays, 4 mg/mL in ethanol for compounds 2 and 3 as well as 2 mg/mL in ethanol for compounds 1, 4, and 5) was prepared in the microplates in triplicate. Gentamicin (0.1 mg/mL in water) and benomyl (25 mg/mL in ethanol) were used as the positive controls against the bacteria and fungi, respectively, while ethanol was the negative control. After dilution, ethanol was evaporated from the wells in a sterile box. A total of 150 µL of bacterial suspension (105 CFU/mL) for the antibacterial assay or 70 µL of LB broth and then 50 µL of a mycelium suspension (OD600 = 0.2 in LB broth) for the antifungal assay was added to each well. The absorbance was measured at 600 nm by a CLARIOstar® Plus microplate reader (BMG LABTECH, Ortenberg, Germany) immediately and after 24 h (B. subtilis at 37 °C, P. syringae pv. tomato, and X. arboricola pv. pruni at 28 °C) or 48 h (C. flaccumfaciens pv. flaccumfaciens and C. michiganensis at 28 °C, R. fascians at 30 °C) incubation by shaking at 500 rpm with a Grant PHMP microplate thermoshaker (Grant Instruments, Royston, UK) or after 72 h incubation without shaking (F. graminearum and B. sorokiniana at 21 °C). The experiments were repeated on two separate occasions.

3.10.2. Determination of Minimal Bactericidal Concentration (MBC) Values

An aliquot (10 µL) was taken from the microplate wells where no bacterial growth was observed after 24 h or 48 h incubation and was then dotted onto the surface of LB (B. subtilis) or NB (C. flaccumfaciens pv. flaccumfaciens and C. michiganensis) agar plates. The MBC was defined as the lowest concentration of the isolated compound at which no colonies formed after 24 h (B. subtilis) or 48 h (C. flaccumfaciens pv. flaccumfaciens and C. michiganensis) incubation at 37 °C or 28 °C, respectively.

4. Conclusions

In summary, a non-targeted, effect-directed phytochemical investigation of a n-hexane leaf extract of S. gigantea led to the bioassay-guided isolation, characterization, and structure elucidation of five compounds, including diangelate solidagoic acid J (1), a previously undescribed cis-clerodane diterpenoid, as well as two known cis-clerodane diterpenoids, solidagoic acid C (2) and solidagoic acid D (3), and two known monoglycerides, 1-linoleoyl glycerol (4) and 1-α-linolenoyl glycerol (5), which are reported here for the first time from this species. The evaluation of their antimicrobial activity against several plant pathogenic bacterial and fungal strains revealed that all isolated compounds exhibited weak to moderate antibacterial activity against C. michiganensis. Compound 1 was the most effective against B. subtilis and C. flaccumfaciens pv. flaccumfaciens, whereas compound 5 demonstrated the highest antibacterial activity against C. michiganensis and R. fascians. The moderate antifungal activity of compounds 2 and 3 was also observed against B. sorokiniana and F. graminearum.
The present study enriches the phytochemical and biological knowledge of S. gigantea and highlights the potential of thin-layer chromatography combined with direct bioautography and mass spectrometry as an effective tool for identifying novel bioactive compounds within a bioassay-guided isolation workflow. Furthermore, the isolated compounds show promising potential to reduce the ecological impact of synthetic pesticides and may serve as leads for the development of more effective, plant-derived pesticide candidates for sustainable plant protection.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/plants14142152/s1. Figures S1–S18: One-dimensional and two-dimensional NMR, HR-ESI-MS(/MS), UV, and ATR-FTIR spectra for compound 1; Figures S19–S29: One-dimensional and two-dimensional NMR and HR-ESI-MS(/MS) spectra for compound 2; Figures S30–S40: One-dimensional and two-dimensional NMR and HR-ESI-MS(/MS) spectra for compound 3; Figures S41–S48: One-dimensional and two-dimensional NMR and HR-ESI-MS(/MS) spectra for compound 4; Figures S49–S56: One-dimensional and two-dimensional NMR and HR-ESI-MS(/MS) spectra for compound 5.

Author Contributions

Conceptualization, funding acquisition, methodology, project administration, and supervision, Á.M.M.; resources, Á.M.M., S.V. and A.D.; investigation, M.B. and S.V.; data curation, visualization, and writing—original draft preparation, M.B.; writing—review and editing, Á.M.M.; microbiological work, P.G.O., Z.B., I.S., J.B. and D.D. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the National Research, Development and Innovation Office of Hungary (project IDs: K128921 and SNN139496; Á.M.M.).

Data Availability Statement

The data supporting the findings of this study are available in the Supporting Information and from the corresponding author upon reasonable request.

Acknowledgments

The authors thank Tamás Gáti (Servier Research Institute of Medicinal Chemistry (SRIMC), Budapest, Hungary) for conducting NMR measurements and Judit Nyiri (Pharmaceutical Chemistry and Technology Department, National Institute of Pharmacy and Nutrition, Budapest, Hungary) for her assistance in measuring optical rotations and recording ATR-FTIR and UV spectra. We are also grateful to Tibor Soós (Organocatalysis Research Group, Institute of Organic Chemistry, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary) for providing access to the Varian NMR spectrometer.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Semple, J.C.; Beck, J.B. Revised Infrageneric Classification of Solidago (Asteraceae: Astereae). Phytoneuron 2021, 10, 1–6. [Google Scholar]
  2. Fursenco, C.; Calalb, T.; Uncu, L.; Dinu, M.; Ancuceanu, R. Solidago virgaurea L.: A Review of Its Ethnomedicinal Uses, Phytochemistry, and Pharmacological Activities. Biomolecules 2020, 10, 1619. [Google Scholar] [CrossRef] [PubMed]
  3. Hejda, M.; Pyšek, P.; Jarošík, V. Impact of Invasive Plants on the Species Richness, Diversity and Composition of Invaded Communities. J. Ecol. 2009, 97, 393–403. [Google Scholar] [CrossRef]
  4. Goossens, E.P.; Mertens, W.; Olde Venterink, H. Solidago gigantea Invasion Homogenizes Soil Properties and Native Plant Communities. Biol. Invasions 2024, 26, 3315–3327. [Google Scholar] [CrossRef]
  5. Pal, R.W.; Chen, S.; Nagy, D.U.; Callaway, R.M. Impacts of Solidago gigantea on Other Species at Home and Away. Biol. Invasions 2015, 17, 3317–3325. [Google Scholar] [CrossRef]
  6. Woźniak, D.; Ślusarczyk, S.; Domaradzki, K.; Dryś, A.; Matkowski, A. Comparison of Polyphenol Profile and Antimutagenic and Antioxidant Activities in Two Species Used as Source of Solidaginis herba—Goldenrod. Chem. Biodivers. 2018, 15, e1800023. [Google Scholar] [CrossRef]
  7. Leuschner, J. Anti-Inflammatory, Spasmolytic and Diuretic Effects of a Commercially Available Solidago gigantea Herb. Extract. Arzneimittelforschung 1995, 45, 165–168. [Google Scholar]
  8. Kołodziej, B. Antibacterial and Antimutagenic Activity of Extracts Aboveground Parts of Three Solidago Species: Solidago virgaurea L., Solidago canadensis L. and Solidago gigantea Ait. J. Med. Plants Res. 2011, 5, 6770–6779. [Google Scholar] [CrossRef]
  9. Anžlovar, S.; Janeš, D.; Dolenc Koce, J. The Effect of Extracts and Essential Oil from Invasive Solidago spp. and Fallopia japonica on Crop-Borne Fungi and Wheat Germination. Food Technol. Biotechnol. 2020, 58, 273–283. [Google Scholar] [CrossRef]
  10. Nkuimi Wandjou, J.G.; Quassinti, L.; Gudžinskas, Z.; Nagy, D.U.; Cianfaglione, K.; Bramucci, M.; Maggi, F. Chemical Composition and Antiproliferative Effect of Essential Oils of Four Solidago Species (S. canadensis, S. gigantea, S. virgaurea and S. × niederederi). Chem. Biodivers. 2020, 17, e2000685. [Google Scholar] [CrossRef]
  11. Benelli, G.; Pavela, R.; Cianfaglione, K.; Nagy, D.U.; Canale, A.; Maggi, F. Evaluation of Two Invasive Plant Invaders in Europe (Solidago canadensis and Solidago gigantea) as Possible Sources of Botanical Insecticides. J. Pest Sci. 2019, 92, 805–821. [Google Scholar] [CrossRef]
  12. Zekič, J.; Vovk, I.; Glavnik, V. Extraction and Analyses of Flavonoids and Phenolic Acids from Canadian Goldenrod and Giant Goldenrod. Forests 2020, 12, 40. [Google Scholar] [CrossRef]
  13. Radusiene, J.; Marska, M.; Ivanauskas, L.; Jakstas, V.; Karpaviciene, B. Assessment of Phenolic Compound Accumulation in Two Widespread Goldenrods. Ind. Crops Prod. 2015, 63, 158–166. [Google Scholar] [CrossRef]
  14. Marksa, M.; Zymone, K.; Ivanauskas, L.; Radušienė, J.; Pukalskas, A.; Raudone, L. Antioxidant Profiles of Leaves and Inflorescences of Native, Invasive and Hybrid Solidago Species. Ind. Crops Prod. 2020, 145, 112123. [Google Scholar] [CrossRef]
  15. Radušienė, J.; Karpavičienė, B.; Marksa, M.; Ivanauskas, L.; Raudonė, L. Distribution Patterns of Essential Oil Terpenes in Native and Invasive Solidago Species and Their Comparative Assessment. Plants 2022, 11, 1159. [Google Scholar] [CrossRef]
  16. Kalemba, D.; Marschall, H.; Bradesi, P. Constituents of the Essential Oil of Solidago gigantea Ait. (Giant Goldenrod). Flavour Fragr. J. 2001, 16, 19–26. [Google Scholar] [CrossRef]
  17. Henderson, M.S.; McCrindle, R.; McMaster, D. Constituents of Solidago Species. Part V. Non-Acidic Diterpenoids from Solidago gigantea var. serotina. Can. J. Chem. 1973, 51, 1346–1358. [Google Scholar] [CrossRef]
  18. Jurenitsch, J.; Maurer, J.; Rain, U.; Robien, W. Diterpenebutenolides in Solidago gigantea. Phytochemistry 1988, 27, 626–627. [Google Scholar] [CrossRef]
  19. Baglyas, M.; Ott, P.G.; Garádi, Z.; Glavnik, V.; Béni, S.; Vovk, I.; Móricz, Á.M. High-Performance Thin-Layer Chromatography—Antibacterial Assay First Reveals Bioactive Clerodane Diterpenes in Giant Goldenrod (Solidago gigantea Ait.). J. Chromatogr. A 2022, 1677, 463308. [Google Scholar] [CrossRef]
  20. Choi, S.Z.; Choi, S.U.; Lee, K.R. Pytochemical Constituents of the Aerial Parts from Solidago virga-aurea var. gigantea. Arch. Pharmacal Res. 2004, 27, 164–168. [Google Scholar] [CrossRef]
  21. Reznicek, G.; Jurenitsch, J.; Michl, G.; Haslinger, E. The First Structurally Confirmed Saponin from Solidago gigantea: Structure Elucidation by Modern NMR Techniques. Tetrahedron Lett. 1989, 30, 4097–4100. [Google Scholar] [CrossRef]
  22. Reznicek, G.; Jurenitsch, J.; Michl, G.; Haslinger, E.; Hiller, K.; Kubelka, W. Structure of Two New Saponins from Solidago gigantea. Planta Med. 1989, 55, 623–624. [Google Scholar] [CrossRef]
  23. Reznicek, G.; Freiler, M.; Schader, M.; Schmidt, U. Determination of the Content and the Composition of the Main Saponins from Solidago gigantea AIT. Using High-Performance Liquid Chromatography. J. Chromatogr. A 1996, 755, 133–137. [Google Scholar] [CrossRef]
  24. Baglyas, M.; Ott, P.G.; Schwarczinger, I.; Nagy, J.K.; Darcsi, A.; Bakonyi, J.; Móricz, Á.M. Antimicrobial Diterpenes from Rough Goldenrod (Solidago rugosa Mill.). Molecules 2023, 28, 3790. [Google Scholar] [CrossRef]
  25. Móricz, Á.M.; Krüzselyi, D.; Ott, P.G.; Garádi, Z.; Béni, S.; Morlock, G.E.; Bakonyi, J. Bioactive Clerodane Diterpenes of Giant Goldenrod (Solidago gigantea Ait.) Root Extract. J. Chromatogr. A 2021, 1635, 461727. [Google Scholar] [CrossRef]
  26. Krüzselyi, D.; Bakonyi, J.; Ott, P.G.; Darcsi, A.; Csontos, P.; Morlock, G.E.; Móricz, Á.M. Goldenrod Root Compounds Active against Crop Pathogenic Fungi. J. Agric. Food Chem. 2021, 69, 12686–12694. [Google Scholar] [CrossRef]
  27. Móricz, Á.M.; Ott, P.G.; Häbe, T.T.; Darcsi, A.; Böszörményi, A.; Alberti, Á.; Krüzselyi, D.; Csontos, P.; Béni, S.; Morlock, G.E. Effect-Directed Discovery of Bioactive Compounds Followed by Highly Targeted Characterization, Isolation and Identification, Exemplarily Shown for Solidago virgaurea. Anal. Chem. 2016, 88, 8202–8209. [Google Scholar] [CrossRef]
  28. Nishidono, Y.; Tanaka, K. New Clerodane Diterpenoids from Solidago altissima and Stereochemical Elucidation via 13C NMR Chemical Shift Analysis. Tetrahedron 2022, 110, 132691. [Google Scholar] [CrossRef]
  29. Nogueira, R.T.; Shepherd, G.J.; Laverde, A., Jr.; Marsaioli, A.J.; Imamura, P.M. Clerodane-Type Diterpenes from the Seed Pods of Hymenaea courbaril var. stilbocarpa. Phytochemistry 2001, 58, 1153–1157. [Google Scholar] [CrossRef]
  30. Manabe, S.; Nishino, C. Stereochemistry of cis-Clerodane Diterpenes. Tetrahedron 1986, 42, 3461–3470. [Google Scholar] [CrossRef]
  31. Miyata, O.; Shinada, T.; Ninomiya, I.; Naito, T. A Facile Conversion of (Z)-2-Alkenoic Esters into the (E)-Isomers with Diphenyl Disulfide. Synthesis 1990, 1990, 1123–1125. [Google Scholar] [CrossRef]
  32. Anthonsen, T.; Henderson, M.S.; Martin, A.; Murray, R.D.H.; McCrindle, R.; McMaster, D. Constituents of Solidago Species. Part IV. Solidagoic Acids A and B, Diterpenoids from Solidago gigantea var. serotina. Can. J. Chem. 1973, 51, 1332–1345. [Google Scholar] [CrossRef]
  33. Starks, C.M.; Williams, R.B.; Goering, M.G.; O’Neil-Johnson, M.; Norman, V.L.; Hu, J.-F.; Garo, E.; Hough, G.W.; Rice, S.M.; Eldridge, G.R. Antibacterial Clerodane Diterpenes from Goldenrod (Solidago virgaurea). Phytochemistry 2010, 71, 104–109. [Google Scholar] [CrossRef] [PubMed]
  34. Lee, S.-J.; Jang, H.-J.; Kim, Y.; Oh, H.-M.; Lee, S.; Jung, K.; Kim, Y.-H.; Lee, W.-S.; Lee, S.-W.; Rho, M.-C. Inhibitory Effects of IL-6-Induced STAT3 Activation of Bio-Active Compounds Derived from Salvia plebeia R.Br. Process Biochem. 2016, 51, 2222–2229. [Google Scholar] [CrossRef]
  35. Gläser, P.; Dawid, C.; Meister, S.; Bader-Mittermaier, S.; Schott, M.; Eisner, P.; Hofmann, T. Molecularization of Bitter Off-Taste Compounds in Pea-Protein Isolates (Pisum sativum L.). J. Agric. Food Chem. 2020, 68, 10374–10387. [Google Scholar] [CrossRef]
  36. Oku, N.; Hayashi, S.; Yamaguchi, Y.; Takenaka, H.; Igarashi, Y. Nostochopcerol, a New Antibacterial Monoacylglycerol from the Edible Cyanobacterium Nostochopsis lobatus. Beilstein J. Org. Chem. 2023, 19, 133–138. [Google Scholar] [CrossRef]
  37. Ogihara, T.; Amano, N.; Mitsui, Y.; Fujino, K.; Ohta, H.; Takahashi, K.; Matsuura, H. Determination of the Absolute Configuration of a Monoglyceride Antibolting Compound and Isolation of Related Compounds from Radish Leaves (Raphanus sativus). J. Nat. Prod. 2017, 80, 872–878. [Google Scholar] [CrossRef]
  38. Li, R.; Morris-Natschke, S.L.; Lee, K.-H. Clerodane Diterpenes: Sources, Structures, and Biological Activities. Nat. Prod. Rep. 2016, 33, 1166–1226. [Google Scholar] [CrossRef]
  39. Herrera-Mayorga, V.; Guerrero-Sánchez, J.A.; Méndez-Álvarez, D.; Paredes-Sánchez, F.A.; Rodríguez-Duran, L.V.; Niño-García, N.; Paz-González, A.D.; Rivera, G. Insecticidal Activity of Organic Extracts of Solidago graminifolia and Its Main Metabolites (Quercetin and Chlorogenic Acid) against Spodoptera frugiperda: An In Vitro and In Silico Approach. Molecules 2022, 27, 3325. [Google Scholar] [CrossRef]
  40. Kabara, J.J. Antimicrobial Agents Derived from Fatty Acids. J. Am. Oil Chem. Soc. 1984, 61, 397–403. [Google Scholar] [CrossRef]
  41. Reiner, D.S.; Wang, C.-S.; Gillin, F.D. Human Milk Kills Giardia Lamblia by Generating Toxic Lipolytic Products. J. Infect. Dis. 1986, 154, 825–832. [Google Scholar] [CrossRef] [PubMed]
  42. Welsh, J.K.; Skurrie, I.J.; May, J.T. Use of Semliki Forest Virus to Identify Lipid-Mediated Antiviral Activity and Anti-Alphavirus Immunoglobulin A in Human Milk. Infect. Immun. 1978, 19, 395–401. [Google Scholar] [CrossRef] [PubMed]
  43. Li, R.; Nie, L.; Wang, Q.; Ouyang, D.; Zhang, L.; Yuan, Y.; Hong, Y.; Wang, J.; Hu, X. Phytochemical Constituents, Chemotaxonomic Significance and Anti-Arthritic Effect of Eucommia ulmoides Oliver Staminate Flowers. Nat. Prod. Res. 2020, 36, 3455–3459. [Google Scholar] [CrossRef] [PubMed]
  44. Bai, J.; Wang, S.; Pan, K.; Luo, H.; Zou, K.; Wang, H. Ligulariatinside A, a New Sesquiterpene Glycoside from Roots of Ligularia veitchiana. Nat. Prod. Res. 2025, 39, 262–268. [Google Scholar] [CrossRef]
  45. Ko, H.N.; Kim, J.E.; Jo, Y.J.; Hong, S.H.; Yang, D.W.; Kim, G.O.; Lee, N.H. Antimelanogenic Effects of Raphanus sativus L. var. niger Roots on α-MSH Stimulated B16F10 Melanoma Cells. Bull. Korean Chem. Soc. 2018, 39, 1254–1258. [Google Scholar] [CrossRef]
  46. Jiang, J.; Yu, X.; Fang, Y.; Zhang, Y.; Li, N.; Wang, K. Chemical Constituents of the Roots of Patrinia scabiosaefolia and the Cytotoxicity of Patrineolignans A and B. Chem. Nat. Compd. 2017, 53, 143–146. [Google Scholar] [CrossRef]
  47. Reuk-ngam, N.; Chimnoi, N.; Khunnawutmanotham, N.; Techasakul, S. Antimicrobial Activity of Coronarin D and Its Synergistic Potential with Antibiotics. BioMed Res. Int. 2014, 2014, 581985. [Google Scholar] [CrossRef]
  48. Yu, R.; Li, X.; Yi, P.; Wen, P.; Wang, S.; Liao, C.; Song, X.; Wu, H.; He, Z.; Li, C. Isolation and Identification of Chemical Compounds from Agaricus blazei Murrill and Their In Vitro Antifungal Activities. Molecules 2023, 28, 7321. [Google Scholar] [CrossRef]
  49. Höller, U.; Wright, A.D.; Matthee, G.F.; Konig, G.M.; Draeger, S.; Aust, H.-J.; Schulz, B. Fungi from Marine Sponges: Diversity, Biological Activity and Secondary Metabolites. Mycol. Res. 2000, 104, 1354–1365. [Google Scholar] [CrossRef]
  50. Peng, B.; Cai, J.; Xiao, Z.; Liu, M.; Li, X.; Yang, B.; Fang, W.; Huang, Y.-Y.; Chen, C.; Zhou, X.; et al. Bioactive Polyketides and Benzene Derivatives from Two Mangrove Sediment-Derived Fungi in the Beibu Gulf. Mar. Drugs 2023, 21, 327. [Google Scholar] [CrossRef]
  51. Kusumah, D.; Wakui, M.; Murakami, M.; Xie, X.; Yukihito, K.; Maeda, I. Linoleic Acid, α-Linolenic Acid, and Monolinolenins as Antibacterial Substances in the Heat-Processed Soybean Fermented with Rhizopus oligosporus. Biosci. Biotechnol. Biochem. 2020, 84, 1285–1290. [Google Scholar] [CrossRef]
  52. Móricz, Á.M.; Ott, P.G.; Yüce, I.; Darcsi, A.; Béni, S.; Morlock, G.E. Effect-Directed Analysis via Hyphenated High-Performance Thin-Layer Chromatography for Bioanalytical Profiling of Sunflower Leaves. J. Chromatogr. A 2018, 1533, 213–220. [Google Scholar] [CrossRef]
Figure 1. Illustration of the invasive spread of Solidago gigantea Ait. (giant goldenrod) in its natural habitat (a), the morphological features of its aerial parts (b), and the corresponding voucher herbarium specimen (accession number: HNHM-TRA 00027284) (c).
Figure 1. Illustration of the invasive spread of Solidago gigantea Ait. (giant goldenrod) in its natural habitat (a), the morphological features of its aerial parts (b), and the corresponding voucher herbarium specimen (accession number: HNHM-TRA 00027284) (c).
Plants 14 02152 g001
Figure 2. UV chromatograms (a) recorded during the preparative flash chromatographic fractionation of fraction B38-39 using a C18 column as a stationary phase and water with 0.1% formic acid–methanol gradient as a mobile phase. TLC chromatograms (b) and bioautograms (c) of flash subfractions B38-39/24-26, B38-39/38-40, B40/30-32, and B40/36-38 with compounds 15, visualized after derivatization with p-anisaldehyde reagent (b) and evaluated via direct bioautography using a Bacillus subtilis antibacterial assay (c). RF values for compounds 15: 0.81 (1), 0.73 (2), 0.71 (3), 0.59 (4), and 0.58 (5). Compounds responsible for the inhibition zone detected in subfraction B38-39/24-26, marked with an asterisk sign (*) (b,c), have not been isolated. TLC–ESI+-MS (d) and TLC–ESI-MS (e) spectra of compound 1 in subfraction B38-39/38-40, recorded using an elution-head based interface followed by a background subtraction, are exemplarily shown along with the assignments.
Figure 2. UV chromatograms (a) recorded during the preparative flash chromatographic fractionation of fraction B38-39 using a C18 column as a stationary phase and water with 0.1% formic acid–methanol gradient as a mobile phase. TLC chromatograms (b) and bioautograms (c) of flash subfractions B38-39/24-26, B38-39/38-40, B40/30-32, and B40/36-38 with compounds 15, visualized after derivatization with p-anisaldehyde reagent (b) and evaluated via direct bioautography using a Bacillus subtilis antibacterial assay (c). RF values for compounds 15: 0.81 (1), 0.73 (2), 0.71 (3), 0.59 (4), and 0.58 (5). Compounds responsible for the inhibition zone detected in subfraction B38-39/24-26, marked with an asterisk sign (*) (b,c), have not been isolated. TLC–ESI+-MS (d) and TLC–ESI-MS (e) spectra of compound 1 in subfraction B38-39/38-40, recorded using an elution-head based interface followed by a background subtraction, are exemplarily shown along with the assignments.
Plants 14 02152 g002
Figure 3. The chemical structures of the isolated compounds (15) with atomic numbering (blue).
Figure 3. The chemical structures of the isolated compounds (15) with atomic numbering (blue).
Plants 14 02152 g003
Figure 4. Key 1H–1H COSY (blue), 1H–13C HMBC (red), and 1H–1H ROESY (green) correlations of solidagoic acid J (1).
Figure 4. Key 1H–1H COSY (blue), 1H–13C HMBC (red), and 1H–1H ROESY (green) correlations of solidagoic acid J (1).
Plants 14 02152 g004
Table 1. 1H NMR (500 MHz) and 13C NMR (126 MHz) spectroscopic data of solidagoic acid J (1) in CDCl3 (δ in ppm, J in Hz). The multiplicity of overlapped (ov.) signals is not reported.
Table 1. 1H NMR (500 MHz) and 13C NMR (126 MHz) spectroscopic data of solidagoic acid J (1) in CDCl3 (δ in ppm, J in Hz). The multiplicity of overlapped (ov.) signals is not reported.
PositionSolidagoic Acid J (1)
δH (ppm), Multiplicity, J (Hz)δC (ppm), Type
1a1.75, m19.6, CH2
1b1.54, ov.
2a2.17, m26.5, CH2
2b
35.91, t (4.0)128.1, CH
4136.2, C
550.0, C
6a2.41, dt (13.9, 2.8)30.1, CH2
6b1.51, ov.
7a1.68, ov.28.0, CH2
7b1.33, m
81.65, ov.37.0, CH
938.7, C
102.32, dd (12.9, 1.5)42.6, CH
11a1.59, ov.30.0, CH2
11b1.22, td (13.7, 4.8)
12a2.26, td (14.3, 2.4)29.4, CH2
12b1.94, td (13.6, 4.7)
13139.1, C
145.72, t (7.1)128.7, CH
154.26, d (7.1)58.7, CH2
16a4.80, d (12.3)61.7, CH2
16b4.66, d (12.3)
170.79, d (6.4)15.8, CH3
184.51, m64.5, CH2
19178.8, C
200.92, s27.0, CH3
1′167.7, C
2′128.0, C
3′6.04, qq (7.2, 1.3)138.3, CH
4′1.97, ov.15.9, CH3
5′1.88, ov.20.8, CH3
1″168.7, C
2″127.7, C
3″6.10, qq (7.2, 1.3)139.3, CH
4″1.97, ov.16.0, CH3
5″1.86, ov.20.7, CH3
ov.: overlapping peaks.
Table 2. The minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values of the isolated compounds (15) and positive controls, gentamicin (Gent) and benomyl (Ben), against the Bacillus subtilis (Bs), Curtobacterium flaccumfaciens pv. flaccumfaciens (Cff), Clavibacter michiganensis (Cm), Pseudomonas syringae pv. tomato (Pstom), Rhodococcus fascians (Rf), and Xanthomonas arboricola pv. pruni (Xap) bacterial strains and against the Bipolaris sorokiniana (Bip) and Fusarium graminearum (Fg) fungal strains given in µg/mL. Gram-positive and Gram-negative bacteria are denoted as G+ and G−, respectively. For compound 1, MIC and MBC values against certain bacterial strains could not be determined due to insufficient sample quantity.
Table 2. The minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values of the isolated compounds (15) and positive controls, gentamicin (Gent) and benomyl (Ben), against the Bacillus subtilis (Bs), Curtobacterium flaccumfaciens pv. flaccumfaciens (Cff), Clavibacter michiganensis (Cm), Pseudomonas syringae pv. tomato (Pstom), Rhodococcus fascians (Rf), and Xanthomonas arboricola pv. pruni (Xap) bacterial strains and against the Bipolaris sorokiniana (Bip) and Fusarium graminearum (Fg) fungal strains given in µg/mL. Gram-positive and Gram-negative bacteria are denoted as G+ and G−, respectively. For compound 1, MIC and MBC values against certain bacterial strains could not be determined due to insufficient sample quantity.
CompoundsBs (G+)Cff (G+)Cm (G+)Rf (G+)Pstom (G−)Xap (G−)BipFg
MICMBCMICMBCMICMBCMICMBCMICMBCMICMBCMICMIC
167>133133>13367>133N/AN/AN/AN/AN/AN/AN/AN/A
2>133>133>133>133133>133>133>133>133>133>133>133>333 b>333 c
3133>133>133>13333>133133>133>133>133>133>133>333 c>333 d
4>133>133>133>13333>133>133>133>133>133>133>133>167>167
5>133>133>133>13317>13333>133>133>133>133>133>167>167
Gent a0.81.70.80.81.71.70.81.70.40.81.71.7
Ben a 1042521
N/A—no data available; a positive control; b 45% inhibition at 333 µg/mL; c 56% inhibition at 333 µg/mL; d 51% inhibition at 333 µg/mL.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Baglyas, M.; Ott, P.G.; Bozsó, Z.; Schwarczinger, I.; Bakonyi, J.; Dlauchy, D.; Darcsi, A.; Varga, S.; Móricz, Á.M. Bioassay-Guided Isolation of cis-Clerodane Diterpenoids and Monoglycerides from the Leaves of Solidago gigantea and Their Antimicrobial Activities. Plants 2025, 14, 2152. https://doi.org/10.3390/plants14142152

AMA Style

Baglyas M, Ott PG, Bozsó Z, Schwarczinger I, Bakonyi J, Dlauchy D, Darcsi A, Varga S, Móricz ÁM. Bioassay-Guided Isolation of cis-Clerodane Diterpenoids and Monoglycerides from the Leaves of Solidago gigantea and Their Antimicrobial Activities. Plants. 2025; 14(14):2152. https://doi.org/10.3390/plants14142152

Chicago/Turabian Style

Baglyas, Márton, Péter G. Ott, Zoltán Bozsó, Ildikó Schwarczinger, József Bakonyi, Dénes Dlauchy, András Darcsi, Szilárd Varga, and Ágnes M. Móricz. 2025. "Bioassay-Guided Isolation of cis-Clerodane Diterpenoids and Monoglycerides from the Leaves of Solidago gigantea and Their Antimicrobial Activities" Plants 14, no. 14: 2152. https://doi.org/10.3390/plants14142152

APA Style

Baglyas, M., Ott, P. G., Bozsó, Z., Schwarczinger, I., Bakonyi, J., Dlauchy, D., Darcsi, A., Varga, S., & Móricz, Á. M. (2025). Bioassay-Guided Isolation of cis-Clerodane Diterpenoids and Monoglycerides from the Leaves of Solidago gigantea and Their Antimicrobial Activities. Plants, 14(14), 2152. https://doi.org/10.3390/plants14142152

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop